The Surprise Pathology Bill After a Skin Biopsy

Why you got a second bill for one biopsy

A skin biopsy is usually two medical services with two separate bills. One clinician removes the tissue in the office; a different physician — a pathologist, often a dermatopathologist at an outside laboratory — examines it under the microscope and writes the diagnosis. Each bills for their own work, frequently on different days and from different systems, which is why a pathology charge can land weeks after the visit you thought you had already paid for.

The surprise has a second layer. Your dermatologist can be fully in your insurance network while the laboratory that reads your slide is not. You never chose that lab, never spoke to it, and may not have known it existed — yet its bill is out of network and can be much larger than expected. Insurance statements can deepen the confusion, because the pathology charge often appears on a separate explanation of benefits, listing a lab name you have never heard of. The biopsy and the reading of the biopsy are two services; the lab that reads it may be out of network even when your doctor is in. None of this is a mistake on the bill. It is how the work is divided, and knowing that in advance is what lets you get ahead of it.

The charges to expect from one biopsy

A single biopsy can generate up to three distinct charges, and seeing them itemized makes the total far less mysterious. The removal of the tissue is one service. The pathologist's interpretation — the professional fee for reading the slide and rendering the diagnosis — is a second. And preparing the specimen into slides can carry its own technical or facility fee, especially when the lab is a separate business.

Medicare and many insurers describe the reading as having a professional component (the pathologist's interpretation) and a technical component (preparing the slide); an independent lab may bill both, while a hospital-based one may split them, which is another reason the number of bills varies. How these are split depends on whether the reading pathologist works inside your clinician's practice or at an independent lab. When everything is under one in-network roof, you may see a single combined bill. When the slide travels to an outside dermatopathology lab, you are far more likely to see separate line items — and the one most likely to be out of network is the pathology fee. If you are weighing the whole cost, the pathology fee cash price is the number people most often forget to ask about.

Knowing which components are on your bill also tells you where to push. A technical fee from an in-network lab is usually not the problem; an out-of-network professional fee is the line most worth questioning, because it is the one that generates the balance the surprise is made of.

Does the No Surprises Act protect you?

Sometimes, but not as fully as people expect. The federal No Surprises Act, effective in 2022, bans surprise balance bills for most emergency care and for out-of-network clinicians who treat you at an in-network facility — the classic example being an out-of-network anesthesiologist or radiologist at an in-network hospital 1Ref 1Centers for Medicare & Medicaid Services (2022).No Surprises: Understand your rights against surprise medical bills.The No Surprises Act bans surprise balance bills for most emergency services and for certain out-of-network services at in-network facilities, capping patient cost-sharing at in-network levels.. For those situations your cost-sharing is capped at in-network levels and the balance bill is prohibited.

A skin biopsy in a dermatology office is a harder fit. The Act's strongest facility protections attach to hospitals, hospital outpatient departments, and surgical centers; a physician's office sending tissue to an outside lab does not always fall inside that frame, which is exactly why the separate pathology bill can still reach you. The protections that most reliably apply to office-based care are the good-faith-estimate rules: if you are uninsured or paying cash, the provider must give you a good faith estimate of expected charges before scheduled care 2Ref 2Centers for Medicare & Medicaid Services (2022).Overview of rules & fact sheets (No Surprises Act).Providers must give uninsured or self-pay patients a good faith estimate of expected charges before scheduled care, with a dispute pathway when charges substantially exceed it., and if the final bill runs at least $400 above that estimate, you can challenge it through a patient-provider dispute resolution process 3Ref 3Centers for Medicare & Medicaid Services (2024).No Surprises Act.An uninsured or self-pay patient billed at least $400 above their good faith estimate may dispute the bill through the patient-provider dispute resolution process..

It is also worth asking whether your state has its own surprise-billing protections, since these vary and sometimes reach settings the federal Act does not — a question your state insurance department can answer.

The same dynamic drives the well-known surprise anesthesia bill after a colonoscopy and the broader problem of balance billing after treatment. The lesson across all of them is the same: the law helps most when you use it before the service, by asking who will be involved and whether they are in your network.

How to prevent the surprise before the biopsy

The most effective move happens before the tissue is taken, in a two-minute conversation at the visit. Ask where the specimen will be sent, whether that laboratory is in your insurance network, and what the biopsy and its reading are expected to cost. If the lab is out of network, you can often ask that the specimen be sent to an in-network lab instead — clinicians can usually accommodate this when asked ahead of time.

A short checklist: - Ask for the CPT codes. The removal and the pathology each have billing codes; with them you can call your insurer for an estimate or check the skin biopsy CPT pricing yourself. - Ask which lab reads it, and whether it is in network. This is the single question that prevents the out-of-network pathology bill. - Request a good faith estimate. If you are uninsured or self-pay, you are entitled to one in writing before scheduled care. - Ask about the cash price. Sometimes the self-pay rate for the pathology is lower than the billed charge that would run through insurance.

If you have insurance, a quick call to the number on your card with the CPT codes will tell you the lab's network status and your likely share before anything is sent. Timing also protects you in a subtler way: asking about cost before a biopsy does not delay urgent care, because a genuinely worrying lesion should still be sampled promptly — the questions take a minute and happen in the same visit. Once the slide has been read at an out-of-network lab, your options narrow to disputing a bill instead of preventing one.

What to do when the bill already arrived

If the pathology bill is already in hand, slow down before paying it — a surprising share of medical bills contain fixable problems, and you have several levers. Start by getting an itemized bill and matching it against your insurer's explanation of benefits so you can see what was billed, what was allowed, and what was applied to you. Confirm whether the lab was truly out of network and whether the service should have been covered.

From there: - Appeal to your insurer if the charge should have been in-network or was denied in error; insurers have formal appeal processes. - Ask the lab for the cash or self-pay price and whether they will match it; this is often lower than the billed amount. - Use the dispute process if you are uninsured or self-pay and the bill exceeded your good faith estimate by $400 or more. - Contact the federal No Surprises Help Desk, a government resource set up to answer questions about surprise bills and your rights, if you believe the Act was violated.

You can also ask the pathology lab directly whether they will re-bill your insurance if the claim was sent incorrectly; clerical errors in which lab or code was used are common and reversible. If the amount is large, ask the billing office about a payment plan or financial assistance, since many labs and practices have hardship policies that are not advertised. Keep notes of every call — who you spoke to and when. If a bill has already gone to collections, you can still dispute it, and collection activity on a charge that is under active dispute may itself be improper, so a collections notice is not the end of your options. This is the same playbook that applies to surprise and balance bills after other kinds of treatment, and a bill that looks final at first frequently is not.

Why the tissue has to be read at all

It helps to know that the pathology step is not an optional upcharge — it is where the diagnosis actually happens. Removing a suspicious spot tells you nothing by itself; the tissue has to be sampled adequately — for a possible melanoma, deep enough to capture the full thickness of the lesion 4Ref 4American Family Physician (2011).Shave and Punch Biopsy for Skin Lesions.For a suspected melanoma, the biopsy should sample the full thickness of the lesion to preserve staging accuracy. — and then examined under a microscope by a pathologist whose interpretation is the actual diagnosis 5Ref 5Swetter SM, Tsao H, Bichakjian CK, et al. (2019).Guidelines of care for the management of primary cutaneous melanoma.The diagnosis of melanoma rests on histopathologic interpretation of the biopsy tissue by a pathologist.. For anything that might be skin cancer, that reading is the answer you were seeking, and for melanoma it also measures how deep the lesion goes, which drives the entire treatment plan.

That is why 'just skip the lab' is never the way to save money on a biopsy. A biopsy that is never read is a procedure with no product — you would have a wound and no answer. If cost is the worry, the place to act is the choice of lab and the estimate, not the reading itself. And if the biopsy came back as a cancer, the pathology fee is the least of what is at stake; the reading is the thing you were paying for all along.

If the diagnosis is serious or uncertain, that same tissue can be sent for a dermatopathology second review — a skin biopsy second opinion — which is a separate, often worthwhile step. Understanding that the tissue, the slides, and the reading are the valuable core of a biopsy reframes the bill: you are not being charged twice for one thing, you are being charged for the removal and, separately, for the answer.